Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3,000 | 1 | 71.3% |
| Consulting Fee | $740.00 | 1 | 17.6% |
| Food and Beverage | $432.00 | 5 | 10.3% |
| Education | $35.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $3,157 | 3 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $740.00 | 1 | $0 (2019) |
| Ivantis, Inc | $153.63 | 1 | $0 (2019) |
| Integra LifeSciences Corporation | $105.53 | 1 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $33.37 | 1 | $0 (2019) |
| Allergan Inc. | $17.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $121.52 | 1 | Horizon Therapeutics plc ($121.52) |
| 2021 | $3,000 | 1 | Horizon Therapeutics plc ($3,000) |
| 2020 | $35.00 | 1 | Horizon Therapeutics plc ($35.00) |
| 2019 | $927.00 | 3 | Merck Sharp & Dohme Corporation ($740.00) |
| 2018 | $105.53 | 1 | Integra LifeSciences Corporation ($105.53) |
| 2017 | $17.95 | 1 | Allergan Inc. ($17.95) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $121.52 | General |
| Category: TEPEZZA | ||||||
| 12/02/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: TEPEZZA | ||||||
| 02/11/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Education | In-kind items and services | $35.00 | General |
| Category: KRYSTEXXA | ||||||
| 10/23/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $740.00 | General |
| 08/27/2019 | Ivantis, Inc | Hydrus (Device) | Food and Beverage | In-kind items and services | $153.63 | General |
| Category: Ophthalmic Surgery | ||||||
| 01/08/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/13/2018 | Integra LifeSciences Corporation | BILAYER WOUND MATRIX BWM (Device), INTEGRA WOUND MATRIX IWM, PRIMATRIX | Food and Beverage | In-kind items and services | $105.53 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 06/13/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: DRY EYE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 930 | 3,998 | $626,336 | $147,968 |
| 2022 | 23 | 1,017 | 4,077 | $725,835 | $160,272 |
| 2021 | 17 | 791 | 3,720 | $503,362 | $126,799 |
| 2020 | 17 | 757 | 2,771 | $535,830 | $119,502 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 33 | 33 | $81,437 | $19,881 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 193 | $44,774 | $17,669 | 39.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 2,950 | $35,400 | $14,547 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $45,311 | $13,553 | 29.9% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 41 | 47 | $93,386 | $13,129 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 181 | $27,024 | $10,896 | 40.3% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Facility | 2023 | 18 | 21 | $46,383 | $10,020 | 21.6% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 13 | 14 | $35,830 | $7,709 | 21.5% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 35 | 43 | $35,178 | $7,194 | 20.4% |
| 67900 | Repair of brow paralysis | Facility | 2023 | 22 | 22 | $52,623 | $6,682 | 12.7% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 17 | 39 | $30,498 | $4,740 | 15.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 100 | 108 | $20,331 | $4,711 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 33 | $12,000 | $4,177 | 34.8% |
| 68810 | Insertion of probe into nasal tear duct | Office | 2023 | 28 | 28 | $21,249 | $3,876 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $12,683 | $3,569 | 28.1% |
| 67961 | Removal of up to 1/4 of eyelid margin and repair of eyelid | Facility | 2023 | 11 | 12 | $17,537 | $3,436 | 19.6% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 30 | 33 | $3,551 | $713.82 | 20.1% |
| 92285 | Photography of content of eyes | Office | 2023 | 34 | 36 | $4,464 | $549.88 | 12.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $1,424 | $529.36 | 37.2% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 21 | 29 | $5,253 | $386.71 | 7.4% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 46 | 46 | $120,904 | $27,806 | 23.0% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2022 | 45 | 54 | $108,117 | $16,328 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 163 | $38,816 | $14,357 | 37.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 17 | 2,950 | $31,275 | $14,346 | 45.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 167 | 167 | $44,756 | $12,707 | 28.4% |
About Peter Timoney, MBBCH
Peter Timoney, MBBCH is a Ophthalmology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1033375597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Timoney, MBBCH has received a total of $4,207 in payments from pharmaceutical and medical device companies, with $121.52 received in 2022. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Honoraria" ($3,000).
As a Medicare-enrolled provider, Timoney has provided services to 3,495 Medicare beneficiaries, totaling 14,566 services with total Medicare billing of $554,542. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery
- Location Lexington, KY
- Active Since 08/04/2008
- Last Updated 07/21/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1033375597
Products in Payments
- TEPEZZA (Drug) $3,122
- Hydrus (Device) $153.63
- BILAYER WOUND MATRIX BWM (Device) $105.53
- KRYSTEXXA (Biological) $35.00
- ACTHAR (Biological) $33.37
- RESTASIS (Drug) $17.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lexington
Dr. John Kitchens, M.d, M.D
Ophthalmology — Payments: $1.2M
Dr. Jeremy Kieval, M.d, M.D
Ophthalmology — Payments: $354,855
Gary Wortz, Md, MD
Ophthalmology — Payments: $195,872
Blake Isernhagen, Md, MD
Ophthalmology — Payments: $188,723
Dr. Bruce Koffler, Md, MD
Ophthalmology — Payments: $100,236
Kunal Kanitkar, M.d, M.D
Ophthalmology — Payments: $75,249